Skip to main content

Companies researching Veklury (remdesivir)

Veklury, the brand name for the antiviral drug remdesivir developed by Gilead Sciences, is given by intravenous injection and is authorized for use in specific COVID‑19 patients.

List of companies that research Veklury (remdesivir)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

  • Gilead Sciences logo
    United StatesEmployees15kRevenue$27BBiotechnology Research
    Veklury (remdesivir)Low confidence
  • Bangor University logo
    United KingdomEmployees2.2kRevenue$3BHigher Education
    Veklury (remdesivir)Low confidence
  • CNRS logo
    FranceEmployees23kRevenue$675MResearch Services
    Veklury (remdesivir)Low confidence
  • University of Alabama at Birmingham logo
    United StatesEmployees17kHigher Education
    Veklury (remdesivir)Low confidence

Showing top companies out of 6 that research Veklury (remdesivir). Get the full list on TheirStack.

Frequently asked questions